Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Thread starter U.S. News
Start date Jul 23, 2026

U.S. News

Guest

Jul 23, 2026

There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Prefix: N/A

Forum: USA News

Start date: Jul 23, 2026

Last reply date: Jul 23, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Jul 23, 2026

Replies: 0

Views: 15

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search